Turanaxyl 10 mg is an oral 4-Chlorodehydromethyltestosterone tablet manufactured by Kalpa Pharmaceuticals and dosed at 10 mg per tablet, supplied in packs of 100 tablets.
Turanaxyl 10 mg contains 4-Chlorodehydromethyltestosterone (also known as dehydrochloromethyltestosterone, DHCMT, or Oral Turinabol), a synthetic anabolic-androgenic steroid developed by Jenapharm in the 1960s and marketed as Oral-Turinabol®. Its defining structural feature is a 4-chloro substitution that prevents aromatization to estrogen, resulting in a non-estrogenic profile.
In clinical and historical contexts, 4-Chlorodehydromethyltestosterone was primarily developed to support recovery after major surgeries, though it became infamous through its misuse in the East German systematic doping program. In non-medical bodybuilding settings, it is commonly referenced for lean, dry strength gains without water retention, often positioned between Dianabol and Anavar in terms of potency and side effect profile.
The compound has a high anabolic-to-androgenic ratio. In the rat Hershberger assay, DHCMT exhibits an anabolic effect of 53 and an androgenic effect of 6 (relative to testosterone baseline of 100 each), yielding a ratio of approximately 8.8. As a 17-alpha-alkylated compound, it is associated with hepatotoxicity, and periodic liver function monitoring is recommended during any use.
Turanaxyl 10 mg is supplied as an oral compressed tablet containing 10 mg of 4-Chlorodehydromethyltestosterone per unit, packaged in a 100-tablet format by Kalpa Pharmaceuticals.
4-Chlorodehydromethyltestosterone is an oral anabolic steroid characterized by its 4-chloro substitution, non-aromatization, and a high anabolic-to-androgenic ratio. Its profile differs significantly from methandienone and other oral anabolics.
The 4-chloro group on the A-ring renders DHCMT resistant to aromatization by the enzyme aromatase (CYP19A1), which requires C-4 hydrogen abstraction for catalysis. This structural feature eliminates the risk of estrogenic side effects such as gynecomastia and water retention.
DHCMT shares the androsta-1,4-dien-3-one backbone with methandrostenolone (Dianabol) and the 4-chloro motif with clostebol, but its combined structural features produce a distinct pharmacological profile. The 1,2-double bond and 17α-methyl group determine AR binding kinetics, metabolic stability, and SHBG interaction.
The compound has an oral bioavailability due to its alkylation at C-17, and a half-life of approximately 16 hours allows for flexible dosing. It is explicitly listed as a prohibited substance under Class S1 (Anabolic Androgenic Steroids) on the World Anti-Doping Agency's Prohibited List.
4-Chlorodehydromethyltestosterone has a half-life of approximately 16 hours, allowing for once or twice daily dosing. This is longer than many other oral anabolic steroids, providing more stable blood levels with less frequent administration.
Kalpa Pharmaceuticals offers several oral anabolic preparations with different compounds, potencies, and intended profiles. The main distinctions involve hepatotoxicity, aromatization potential, and anabolic-to-androgenic ratios.
For those comparing oral options, Dianoxyl 10 (methandienone) is a potent bulking oral but is aromatizable and associated with water retention. Anadroxyl (oxymetholone) is another potent mass-building oral, generally considered more hepatotoxic. Oxandroxyl 10 (oxandrolone) and Stanoxyl 10 (stanozolol) are non-aromatizing oral alternatives often referenced for cutting phases, with different side effect profiles.
The information below is provided for educational reference only. 4-Chlorodehydromethyltestosterone is a controlled anabolic steroid; medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring. Non-medical use falls outside approved indications.
In documented athletic protocols, 4-Chlorodehydromethyltestosterone was administered at 10 mg per day over 3 months in female athletes, and up to 40 mg per day for males in periodized cycles. In non-medical bodybuilding contexts, DHCMT is commonly referenced at 40–60 mg per day for males and 2.5–10 mg per day for females, with cycles not exceeding 6–8 weeks.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Historical athletic (female) | 5–15 mg per day | Once daily |
| Historical athletic (male) | Up to 40 mg per day | Divided doses |
| Bodybuilding (non-medical male) | 40–60 mg per day | Divided doses (AM/PM) |
| Bodybuilding (non-medical female) | 2.5–10 mg per day | Once daily |
In non-medical bodybuilding contexts, 4-Chlorodehydromethyltestosterone is commonly used during cutting phases or as a dry strength oral. It is often stacked with injectable testosterone preparations or other non-aromatizing compounds. The compound is suppressive at effective bodybuilding doses, so a testosterone base or post-cycle therapy plan is commonly referenced.
Cycle duration in non-medical use is typically limited to 6–8 weeks due to the compound's 17-alpha-alkylated structure and associated liver stress. Bloodwork and liver function monitoring are advised if any use occurs.
4-Chlorodehydromethyltestosterone is associated with hepatotoxicity as a 17-alpha-alkylated compound. A 2018 case report described two male bodybuilders who developed acute cholestatic hepatitis requiring hospitalization after ingesting 17α-alkylated AAS including DHCMT. TUDCA (500–1000 mg/day) and strict liver bloodwork are commonly referenced in non-medical contexts.
Aromatase inhibitors such as Arimixyl 1 mg are not relevant for DHCMT since it does not aromatize. Blood pressure, liver enzymes, and lipid profiles should be monitored during any use.
4-Chlorodehydromethyltestosterone is suppressive at bodybuilding doses. In non-medical contexts, standard SERM PCT typically starts 3 days after the last dose due to the short half-life (no ester to clear). Nolvadex at 40/40/20/20 mg over 4 weeks or Clomid at 50/50/25/25 mg is commonly referenced. If running on top of a cruise/TRT dose of testosterone, no PCT is needed.
Agents such as Nolvaxyl 20 mg or Clomixyl 50 mg are commonly discussed for this purpose. Bloodwork at 4–6 weeks post-PCT can confirm recovery.
Dosing strategies and support protocols should be adjusted based on experience level, health status, and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
4-Chlorodehydromethyltestosterone is a controlled anabolic steroid with significant hepatic, cardiovascular, and endocrine effects. Medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring.
4-Chlorodehydromethyltestosterone was discontinued as a pharmaceutical in 1994 but remains prohibited in sports at all times under WADA Class S1. It is regulated as a Schedule III controlled substance in the United States.
Non-medical use at supraphysiologic doses falls outside approved indications and can substantially increase exposure to hepatotoxic, cardiovascular, and endocrine adverse effects.
4-Chlorodehydromethyltestosterone is a controlled substance and is prohibited in sports. Non-medical use is associated with serious health risks, including liver injury, cardiovascular events, and hormonal suppression.
Hepatotoxicity is a primary concern with DHCMT. A 2018 case report described a 28-year-old bodybuilder who developed severe cholestatic hepatitis with hyperbilirubinemia (620 μmol/L) and elevated alkaline phosphatase (251 IU/L) after taking DHCMT at 60 mg per day for 2 months. Symptoms included pruritus, jaundice, discolored stools, and dark urine.
Cardiovascular effects include decreased HDL cholesterol and increased LDL cholesterol. These changes are associated with increased atherosclerosis risk.
Endocrine effects include suppression of endogenous testosterone production, which can lead to testicular atrophy and hormonal imbalances. In women, virilization signs such as voice deepening and clitoral sensitivity may occur and can be irreversible.
Pre-existing cardiovascular disease, liver disease, diabetes, and prostate conditions require careful evaluation before any consideration of DHCMT use.
Women should be monitored for signs of virilization, and use should be discontinued at the first sign of voice changes or clitoral sensitivity.
Medically supervised DHCMT therapy would typically involve periodic liver function tests, lipid profile assessment, and evaluation of hormonal status. Blood pressure should also be monitored.
Any use of 4-Chlorodehydromethyltestosterone should be accompanied by appropriate monitoring and medical supervision where possible.
Store in a cool, dry place away from direct light and moisture. Keep tablets in the original packaging until use. Keep out of reach of children.
Turanaxyl 10 mg is supplied through the official Kalpa Pharmaceuticals distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Kalpa Pharmaceuticals distribution chain.
To verify your Turanaxyl 10 mg product, use the security code on the packaging and cross-check it on the Kalpa official site. Original Kalpa Pharmaceuticals presentation and packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve tablet integrity and stability throughout shelf life.
Store Turanaxyl 10 mg in a cool, dry place away from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the tablets.
Keep the tablets in their original packaging until use. Do not use if the packaging is damaged or if the tablets appear abnormal in color or texture.
Keep out of reach of children. Follow proper handling practices for oral medications.
Answers to common questions about Turanaxyl 10 mg, 4-Chlorodehydromethyltestosterone, dosing, side effects, and product specifications.
Turanaxyl 10 mg contains 4-Chlorodehydromethyltestosterone, which was historically developed to support recovery after major surgeries but was discontinued as a pharmaceutical in 1994. In non-medical bodybuilding contexts, it is commonly referenced for lean, dry strength gains without water retention, though such use falls outside approved medical indications.
4-Chlorodehydromethyltestosterone has a half-life of approximately 16 hours, allowing for once or twice daily dosing. In non-medical bodybuilding contexts, doses at 40 mg or higher are often split into AM/PM administrations to maintain more stable blood levels.
4-Chlorodehydromethyltestosterone is suppressive at bodybuilding doses. In non-medical contexts, standard SERM PCT typically starts 3 days after the last dose due to the short half-life (no ester to clear). Nolvadex at 40/40/20/20 mg over 4 weeks or Clomid at 50/50/25/25 mg is commonly referenced. Agents such as Nolvaxyl 20 mg or Clomixyl 50 mg are commonly discussed for this purpose.
4-Chlorodehydromethyltestosterone is a synthetic androgen that binds to the androgen receptor, promoting nitrogen retention and protein synthesis. Its 4-chloro substitution prevents aromatization to estrogen, resulting in a non-estrogenic profile with no water retention.
Historical East German data documented strength improvements within weeks of administration in female athletes taking 10 mg per day. In non-medical bodybuilding contexts, users often report noticeable effects within the first two to three weeks, though individual response varies.
There is no single oral steroid that is universally best. 4-Chlorodehydromethyltestosterone is commonly referenced for lean, dry gains without water retention, positioned between Dianabol and Anavar in potency and side effect profile. Other orals such as Dianoxyl 10, Anadroxyl, and Stanoxyl 10 have different potency, side effect, and aromatization profiles.
Both are oral 17-alpha-alkylated anabolic steroids. 4-Chlorodehydromethyltestosterone has a 4-chloro substitution that prevents aromatization, resulting in a non-estrogenic profile. Methandienone (Dianabol) is aromatizable and associated with water retention and estrogenic side effects. In the Hershberger assay, DHCMT has an anabolic-to-androgenic ratio of approximately 8.8 versus 2.0 for methandienone.
Both are non-aromatizing oral anabolic steroids commonly referenced for cutting phases. 4-Chlorodehydromethyltestosterone is 17-alpha-alkylated, while oxandrolone is also 17-alpha-alkylated but has a milder side effect profile. Limited comparative data suggest Anavar may be harder on lipids, while DHCMT may be somewhat harder on the liver.
In historical athletic protocols, female athletes were administered 10 mg per day over 3 months. In non-medical bodybuilding contexts, 40–60 mg per day is commonly referenced for males, with 10 mg representing a low dose. Even at lower doses, 4-Chlorodehydromethyltestosterone carries hepatotoxic risk.
Turanaxyl 10 mg is labeled at 10 mg of 4-Chlorodehydromethyltestosterone per tablet. It is supplied in packs of 100 tablets, giving 1,000 mg of total labeled content per pack.
Yes, 4-Chlorodehydromethyltestosterone and its long-term metabolites are detectable in urine samples for extended periods. A controlled administration study found the long-term metabolite M3 detectable for 45 days after a single 5 mg oral dose in one volunteer, with detection windows between 9.9 and 44.9 days across volunteers.
Laboratory testing information for Turanaxyl 10 mg is not currently available in this product listing. Kalpa Pharmaceuticals products are manufactured under pharmaceutical-grade conditions, but independent lab reports are not published for this specific product at this time.
Been using the TBOL for about 2 weeks now running it at 40mg per workout day and 30mg on off days. I have had KP Turanaxyl before and this is definitely the same product. Good clean energy all day with lasting endurance both through my day and at the gym. Good pumps and prolonged workouts coupled with a general feeling of well being. Stacking this with another sources test/eq for great results. The first day I took the TBOL I felt the usual great effects, was in a good mood, had bursts of energy, and at the gym my workout was noticeably more intense, added more reps than usual to most of my sets just because I could easily.
TBOL is without a doubt my favorite oral steroid, and I have only used KP's TBOL and will continue to only use KP TBOL any chance I get. I highly recommend it to anyone who has no tried it yet, it's a great departure from DBOL with leaner but better quality sustainable muscle growth. KalpaPharm.com provided me with a tried and true product and I would not hesitate to use their service again in the future.
Good product and good feeling with the Turanaxyl. I got lot of strength and good quality gains.
Please log in to write Turanaxyl 10 mg review.
February 9, 2021
Tbol kicked in instantly and I gained 10 pounds in the first 10 days. After 15 days my strength had gone up quite a bit as well and I made new PR's in all lifts.